{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-117492","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.611334+00:00","generated_at":"2026-06-08T03:56:22.250332+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Orchestra BioMed files 8-K furnishing Q4 2023 investor presentation","bullets":["Company furnished investor presentation as Exhibit 99.1 for use at conferences.","Presentation is furnished under Regulation FD and not deemed filed for liability purposes.","CEO David P. Hochman signed the report on November 14, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-117492","json":"https://secwatch.observer/filing/0001104659-23-117492.json","markdown":"https://secwatch.observer/filing/0001104659-23-117492.md","text":"https://secwatch.observer/filing/0001104659-23-117492.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923117492/0001104659-23-117492-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923117492/tm2330668d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:56:22.250332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}